glp-1/gip dual agonist mechanism of action Mechanisms and effects of GLP‐1 receptor agonists and Mechanisms of action of GLP-1

The development of dual GIPRGLP1R coagonists that bind to either one or the other receptor (sequence-mixed dual agonists) has emerged as an innovative therapeutic strategy for obesity and type 2 diabetes

manufactured in cGMP-certified facilities, third-party tested for purity, and non-GMO, gluten-free, with zero artificial additives or fillers

GLP-1/GIP Therapy Discontinuation: Why the How Matters One of the most-discussed challenges with GLP-1/GIP agonists such as tirzepatide (Mounjaro) is weight regain after stopping therapy

We highly encourag

Learn what the ads don't tell you, and how lifestyle medicine offers a more lasting path.

At the same time, ultra-long-acting injectables are emerging as another theme of innovation